KIRSTEN MOOTZ: Open Payments
NPI 1912674367 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,009 in 96 payments from 15 companies in 2025. Trend: 2023 $1,908 · 2024 $2,165 · 2025 $2,009
Food & beverage: $2,009
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $441 |
| Janssen Biotech, Inc. | 15 | $430 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $328 |
| Regeneron Healthcare Solutions, Inc. | 8 | $178 |
| Novo Nordisk Inc | 6 | $140 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $128 |
| Madrigal Pharmaceuticals | 6 | $98 |
| Celltrion USA Inc. | 3 | $69 |
| Ardelyx, Inc. | 4 | $64 |
| GENZYME CORPORATION | 2 | $54 |
Products named: TREMFYA, ENTYVIO, RINVOQ, DUPIXENT, Wegovy, XIFAXAN, REZDIFFRA, VEGZELMA.
Industry payments across KY — which companies pay providers there.
